Assignee
CERUS CORP
US68 patents
Top patents by PatentIndex Score
US6544727B1Apr 8, 2003
Methods and devices for the removal of psoralens from blood products
CERUS CORP154 citations98
US6258319B1Jul 10, 2001
Device and method for photoactivation
CERUS CORP120 citations97
US5691132ANov 25, 1997
Method for inactivating pathogens in red cell compositions using quinacrine mustard
CERUS CORP83 citations97
US6709810B2Mar 23, 2004
Methods for quenching pathogen inactivators in biological materials
CERUS CORP39 citations96
US6503699B1Jan 7, 2003
Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens
CERUS CORP33 citations96
US6469052B2Oct 22, 2002
Compounds for the photodecontamination of pathogens in blood
CERUS CORP33 citations96
US6410219B1Jun 25, 2002
Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding group
CERUS CORP54 citations96
US6270952B1Aug 7, 2001
Methods for quenching pathogen inactivators in biological materials
CERUS CORP61 citations96
US6218100B1Apr 17, 2001
5′-primary aminoalkyl psoralen compositions with platelets
CERUS CORP42 citations96
US6194139B1Feb 27, 2001
Methods for photodecontamination of pathogens in blood
CERUS CORP34 citations96
US6177441B1Jan 23, 2001
Treating red blood cell solutions with anti-viral agents
CERUS CORP58 citations96
US6171777B1Jan 9, 2001
Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety
CERUS CORP68 citations96
US6143490ANov 7, 2000
Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety
CERUS CORP48 citations96
US6017691AJan 25, 2000
4'-primary aminopsoralen and platelet compositions
CERUS CORP58 citations96
US5965349AOct 12, 1999
Methods of photodecontamination using synthetic media
CERUS CORP73 citations96
US5908742AJun 1, 1999
Synthetic media for blood components
CERUS CORP81 citations96
US5871900AFeb 16, 1999
Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens
CERUS CORP70 citations96
US5712085AJan 27, 1998
5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium
CERUS CORP57 citations96
US5654443AAug 5, 1997
Compounds for the photo decontamination of pathogens in blood
CERUS CORP45 citations96
US5625079AApr 29, 1997
Synthesizing psoralen compounds useful as intermediates
CERUS CORP48 citations96
US7037642B2May 2, 2006
Removing compounds from blood products with porous particles immobilized in a matrix
CERUS CORP53 citations95
US7025877B1Apr 11, 2006
Processing set for processing and treating a biological fluid
CERUS CORP45 citations95
US6093725AJul 25, 2000
Frangible compounds for pathogen inactivation
CERUS CORP69 citations95
US5854967ADec 29, 1998
Device and method for photoactivation
CERUS CORP27 citations95
US5709991AJan 20, 1998
Proralen inactivation of microorganisms and psoralen removal
CERUS CORP95 citations95
US5683661ANov 4, 1997
Device and method for photoactivation
CERUS CORP41 citations95
US5593823AJan 14, 1997
Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
CERUS CORP109 citations95
US6680025B2Jan 20, 2004
Device and method for photoactivation
CERUS CORP31 citations94
US6433343B1Aug 13, 2002
Device and method for photoactivation
CERUS CORP69 citations94
US6686480B2Feb 3, 2004
Compounds for the photodecontamination of pathogens in blood
CERUS CORP33 citations93
US6420570B1Jul 16, 2002
Psoralen compounds
CERUS CORP34 citations93
US6004741ADec 21, 1999
Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
CERUS CORP35 citations93
US6004742ADec 21, 1999
Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens
CERUS CORP30 citations93
US5972593AOct 26, 1999
Method for the photo-decontamination of pathogens in blood using 4'-primary amino psoralens
CERUS CORP25 citations93
US7655392B2Feb 2, 2010
Quenching methods for red blood cell inactivation process
CERUS CORP30 citations92
US7611831B2Nov 3, 2009
Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
CERUS CORP29 citations92
US7293985B2Nov 13, 2007
Methods for quenching pathogen inactivators in biological materials
CERUS CORP25 citations92
US6514987B1Feb 4, 2003
Frangible compounds for pathogen inactivation
CERUS CORP52 citations92
US6455286B1Sep 24, 2002
Psoralens for pathogen inactivation
CERUS CORP26 citations92
US6133460AOct 17, 2000
Psoralens for pathogen inactivation
CERUS CORP36 citations92
US5618662AApr 8, 1997
Intravenous administration of psoralen
CERUS CORP35 citations92
US7105093B2Sep 12, 2006
Processing set and methods for processing and treating a biological fluid
CERUS CORP17 citations91
US7068361B2Jun 27, 2006
Apparatus, systems and methods for processing and treating a biological fluid with light
CERUS CORP24 citations91
US6951713B2Oct 4, 2005
Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
CERUS CORP47 citations91
US6949753B2Sep 27, 2005
Device and method for photoactivation
CERUS CORP15 citations91
US6586749B2Jul 1, 2003
Device and method for photoactivation
CERUS CORP30 citations91
US6461567B1Oct 8, 2002
Device and method for photoactivation
CERUS CORP27 citations91
US6281225B1Aug 28, 2001
Inhibiting proliferation of arterial smooth muscle cells
CERUS CORP81 citations91
US9713627B2Jul 25, 2017
Pathogen-inactivated red blood cell compositions
CERUS CORP15 citations89
US10799533B2Oct 13, 2020
Plasma compositions and methods of use thereof
CERUS CORP11 citations81
Showing the top 50 of 68 patents by PatentIndex Score.